Entering text into the input field will update the search result below

Premarket Gainers as of 9:05 am (02/15/2018)

Feb. 15, 2018 9:21 AM ETMoleculin Biotech, Inc. (MBRX) StockBy: Gaurav Batavia, SA News Editor1 Comment
  • NASDAQ:MBRX +48% on major breakthrough to develop a new cancer treatment.
  • ARGS +22% on issuance of U.S. patent covering the strain-independent amplification of human immunodeficiency virus.
  • AMAG +19% as FDA grants AMAG Pharma's Makena subcutaneous auto-injector.
  • SEDG +17% on Q4 result.
  • TRIP +15% on Q4 result.
  • ATRS +14% as FDA grants AMAG Pharma's Makena subcutaneous auto-injector.
  • SHLM +10% on being acquired by LyondellBasell (LYB).
  • TEVA +9% on Berkshire investment.
  • OMER +8% as OMS721 shows treatment effect in mid-stage HCT-TMA study.
  • AVP +8% on Q4 result.
  • CTL +8% on Q4 result.
  • MARA +8% on expanding cryptocurrency mining operations.
  • YNDX +7% on Q4 result.
  • CSCO +7% on Q2 result.
  • CARA +7%.
  • RIOT +6% on entering into a definitive agreement to acquire additional cryptocurrency mining equipment.
  • OSTK +5%.
  • DPW +5%.

Recommended For You

About MBRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MBRX--
Moleculin Biotech, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.